The mutation frequency of the CCNB1 gene was comparatively high in prostate cancer, ovarian epithelial tumor, ACC, endometrial cancer, and bladder cancer, highlighting the need to investigate the link between CCNB1 mutations and urogenital system cancers. Here, CCNB1 is linked to endometrial cancer.